Astellas - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

news

Third Harmonic, led by former Audentes CEO, launches with $155M in funding

Third Harmonic Bio, a biotech startup founded in 2019 by Atlas Venture, officially launched on Wednesday with $105 million in new funding to advance development of an...

18 February 2022 news Astellas | Audentes

Continue Reading →

news

Johnson & Johnson has the most bucks for biopharma M&A, Astellas the easiest target: analyst

The $62 billion Takeda-Shire deal surprised everyone—and worries some—as Takeda is borrowing an enormous $31 billion to help pay for the purchase. Does it refresh the...

1 June 2018 news Astellas | biopharma

Continue Reading →